483
Bio-RadBio-Rad – FDA 483, Mar 7, 2023
Record Details
Bio-Rad in Steenvoorde, France, was cited for multiple deficiencies related to its manufacturing processes and quality system for biologic IVD and biologic substance products. Observations included unapproved production procedures, inadequate documentation of acceptance activities, and failures in corrective and preventive actions. The inspection also found issues with the use of expired materials and insufficient equipment calibration.
View Company Profile
ID · 4680bd26-3bac-49ee-8e47-18b79e63a1d0
Other documents for Bio-Rad
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.